Drug
Ve303
Ve303: highest development phase Phase 3, developed by Vedanta Biosciences, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Vedanta Biosciences, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| VE303 NCT06237452 | Phase 3 | Clostridium Difficile |
Latest
No recent events.
Follow Ve303 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.